● Recruiting

Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis

Condition: Myasthenia Gravis, Generalized · Sponsor: AstraZeneca

PhaseN/A

Planned participants50

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The Polish multicentre observational (non-interventional) study aiming to collect data on the management and clinical outcomes of patients with gMG that received ravulizumab.

This description comes directly from the study's public registry record.

Talk to the study team

AstraZeneca Clinical Study Information Center · 1-877-240-9479 · information.center@astrazeneca.com

Always discuss trial participation with your own doctor first.

Locations (12)

Research Site	Bydgoszcz, Poland	Recruiting
Research Site	Gdansk, Poland	Recruiting
Research Site	Katowice, Poland	Recruiting
Research Site	Krakow, Poland	Recruiting
Research Site	Lodz, Poland	Recruiting
Research Site	Lublin, Poland	Recruiting
Research Site	Poznan, Poland	Withdrawn
Research Site	Poznan, Poland	Not Yet Recruiting
Research Site	Szczecin, Poland	Recruiting
Research Site	Szczecin, Poland	Not Yet Recruiting
Research Site	Warsaw, Poland	Recruiting
Research Site	Wroclaw, Poland	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06909253